ECMO in Cardiogenic Shock: Time Course of Blood Biomarkers and Associated Mortality.

ABSTRACT:

Background

Veno-arterial extracorporeal membrane oxygenation (va-ECMO) is a temporary life support for severe cardiogenic shock, gaining time for organ recovery, permanent assistance, or transplantation. In this work, we aimed to investigate the trends of blood biomarkers over the period of ECMO support and their role in patient outcome.

Methods

This retrospective study comprised patients receiving va-ECMO support over the period of 14 years at a tertiary university center.

Results

Of 435 patients, 62% (268/435) survived to discharge, and the most frequent adverse event was hemorrhage (46%), followed by thrombosis (25%). Deceased patients had increased blood levels of C-reactive protein, procalcitonin, and white blood cells during the whole observation period, with hi

SUBMITTER: Rajsic S 

PROVIDER: S-EPMC9776439 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature